newsfilter
← Latest News
FDA Approved Drugs·

Approval of Xacduro, Nda #216974 (Type 1 - New Molecular Entity and Type 4 - New Combination)

Approval Date: 05/23/2023; Drug Name: Xacduro, Nda #216974; Active Ingredients: SULBACTAM;DURLOBACTAM; Company: Entasis Therapeutics Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity and Type 4 - New Combination; Application Number: 216974

Company
ENTASIS THERAPEUTICS INC
Keywords
ENTASIS THERAPEUTICS INC